Resources | NITAG RESOURCE CENTER

2024 ∙ NACI

NACI Updated recommendations on human papillomavirus vaccines

2024 ∙ NACI

Economic Evidence Supplementary Appendix to the Recommendations for Public Health Programs on the Use of Pneumococcal Vaccines in Children, Including the Use of 15-Valent and 20-Valent Conjugate Vaccines

2024 ∙ NACI

Recommendations for public health programs on the use of pneumococcal vaccines in children, including the use of 15-valent and 20-valent conjugate vaccines

2023 ∙ Vraga, Emily K. Brady, Sonya S. Gansen, Chloe Khan, Euna Mehnaz Bennis, Sarah L. Nones, Madalyn Tang, Rongwei Srivastava, Jaideep Kulasingam, Shalini

A review of HPV and HBV vaccine hesitancy, intention, and uptake in the era of social media and COVID-19

2023 ∙ de Sousa Gomes, M. L. dos Santos Moura, N. de Carvalho Magalhães, L. da Silva, R. R. Silva, B. G. S. Rodrigues, I. R. Sales, L. B. F. Oriá, M. O. B.

Systematic literature review of primary and secondary cervical cancer prevention programs in South America

2023 ∙ Farrar, J. L. Childs, L. Ouattara, M. Akhter, F. Britton, A. Pilishvili, T. Kobayashi, M.

Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults

2023 ∙ Novilla, M. L. B. Goates, M. C. Redelfs, A. H. Quenzer, M. Novilla, L. K. B. Leffler, T. Holt, C. A. Doria, R. B. Dang, M. T. Hewitt, M. Lind, E. Prickett, E. Aldridge, K.

Why Parents Say No to Having Their Children Vaccinated against Measles: A Systematic Review of the Social Determinants of Parental Perceptions on MMR Vaccine Hesitancy

2023 ∙ ACIP

Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023

2023 ∙ CAVEI

update of the CAVEI recommendation on vaccination against HPV

2023 ∙ NACI

Recommendations on the use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: Economic evidence supplementary appendix